Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Image Analysis
100%
Image-based
100%
Synergistic Drug Combination
100%
Triple-negative Breast Cancer
100%
Computational Analysis
100%
Drug Profiling
100%
Combined Application
100%
Ispinesib
60%
Drug Combination
40%
Vinblastine
40%
Triple-negative Breast Cancer Cells
40%
Compound Profiles
40%
High-content Screening
20%
Cancer Cell Growth
20%
In(III)
20%
Malignancy
20%
Biologically Active Substances
20%
Therapeutic Potential
20%
Fluorescence Microscopy
20%
Tumor Growth
20%
Synergistic Interaction
20%
Breast Cancer Cell Lines
20%
Mitotic Spindle
20%
Proteinase Inhibitor
20%
Combination Treatment
20%
Motor Protein
20%
Antitumor Activity
20%
Cellular Phenotype
20%
Apoptosis Induction
20%
Mitotic Arrest
20%
Orthotopic Model
20%
Synergism
20%
Drug Treatment
20%
Skin Fibroblasts
20%
New Therapeutics
20%
FDA-approved Drugs
20%
Microtubule-targeting Drugs
20%
Effective Compounds
20%
Multidrug Therapy
20%
Treatment Combination
20%
Monastrol
20%
Image-based Analysis
20%
Experimental Biology
20%
Hard to Treat
20%
Qualitative Interaction
20%
Monopolar
20%
Image-based Profiling
20%
Medicine and Dentistry
Combination Drug
100%
Triple Negative Breast Cancer
100%
Drug Analysis
100%
Ispinesib
42%
Cancer
28%
Vinblastine
28%
High-Content Screening
14%
Tumor Progression
14%
Cancer Growth
14%
Fibroblast
14%
Programmed Cell Death
14%
Fluorescence Microscopy
14%
Breast Cancer Cell Line
14%
Antineoplastic Activity
14%
Microtubule
14%
Mitosis Spindle
14%
Drug Delivery System
14%
Mitosis Inhibition
14%
Combination Drug Therapy
14%
Monastrol
14%
Motor Protein
14%
Polypharmacy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Drug
100%
Triple Negative Breast Cancer
100%
Ispinesib
42%
Synergism
28%
Vinblastine
28%
Mouse Model
14%
Cancer Growth
14%
Tumor Growth
14%
Fluorescence Microscopy
14%
Pharmacotherapy
14%
Antitumor Activity
14%
High-Content Screening
14%
Drug Delivery System
14%
Polypharmacy
14%
Molecular Motor
14%
Monastrol
14%